Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer.
Xie CK, Liao CY, Lin HY, Wu YD, Lu FC, Huang XX, Wang ZW, Li G, Lin CF, Hu JF, Chen YH, Li QW, Chen LQ, Chen HX, Chen S.
Xie CK, et al. Among authors: wang zw.
Mol Cancer. 2024 Sep 30;23(1):215. doi: 10.1186/s12943-024-02128-2.
Mol Cancer. 2024.
PMID: 39350121
Free PMC article.